NICE to tackle obesity
Guidance on exercise, play and sport for pre-school and school age children to reduce obesity is to be produced by the National Institute for Health and Clinical Excellence.
This was included in a list
of new referrals to the institute by health
minister Caroline Flint this week. NICE has also been asked to produce
guidance on health education to improve sexual health behaviour and guidance
on alcohol consumption.
Guidance on 12 new treatments already under consideration by NICE is
to be produced more quickly by transferring them to the faster single
technology appraisal process.
New referrals to the institute’s STA process include idaraparinux
sodium to prevent stroke and recurrent venous thromboembolism, abatacept
and rituximab (rheumatoid arthritis), adalimumab and leflunomide (psoriatic
arthritis), alteplase (ischaemic stroke), varenicline (smoking cessation)
and ruboxistaurin (diabetic eye disease).
Multiple technology appraisals have also been ordered for neuroimaging
in first onset psychosis, cochlear implants for deafness, continuous
positive airway pressure for sleep apnoea/hypopnoea and certolizumab
and natalizumab to treat Crohn’s disease.
Full details of the new
appraisal programme |
The
Pharmaceutical Journal
Acrobat
Reader